Lewis B. Silverman

A phase I clinical trial of the notch inhibitor MK-0752 in patients with T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) and other leukemias.

J. Aster, L. Silverman, W. Stock, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Failure to define window of time for autologous tumor vaccination in patients with newly diagnosed or relapsed acute lymphoblastic leukemia.

D. Neuberg, S. Sallan, L. Silverman, 2005, Experimental hematology.

Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia

D. Neuberg, J. Kutok, S. Sallan, 2015, The Pharmacogenomics Journal.

Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia

Traci M. Blonquist, D. Neuberg, S. Sallan, 2015, Pediatric blood & cancer.

A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia

L. Silverman, P. Steinherz, P. Gaynon, 2009, Leukemia.

Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981–1995)

A. Moghrabi, B. Asselin, L. Clavell, 2000, Leukemia.

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.

Donna Neuberg, Steven M Kornblau, Johannes Köster, 2016, Cancer cell.